Completed PHASE3 INTERVENTIONAL 3-arm NCT01675206

Dose Defining Study for the Administration of Vitamin K2 Supplements in Hemodialysis Patients

Randomized Prospective Open Interventional Multi-centre Study on Finding the Optimal Dose of Vitamin K2 Supplements for Hemodialysis Patients

Sponsor: Rogier Caluwe

Conditions Vascular Calcification

Interventions Vitamin K2 supplementation

Updated 5 times since 2017 Last updated: Aug 25, 2012 Started: May 31, 2011 Primary completion: Sep 30, 2011 Completion: Apr 30, 2012

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE3 trial investigates Vascular Calcification and is currently completed. Rogier Caluwe leads this study, which shows 5 recorded versions since 2011 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE3
Jan 2021 — Jul 2024 [monthly]

Completed PHASE3
Jun 2018 — Jan 2021 [monthly]

Completed PHASE3
Jan 2017 — Jun 2018 [monthly]

Completed PHASE3

First recorded

May 2011

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Rogier Caluwe

Data source: Onze Lieve Vrouw Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.